The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $27.99

Today's change+0.27 +0.97%
Updated June 27 11:51 AM EDT. Delayed by at least 15 minutes.
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $27.99

Today's change+0.27 +0.97%
Updated June 27 11:51 AM EDT. Delayed by at least 15 minutes.

Boston Scientific Corp crosses above 20-day moving average

Boston Scientific Corp is up today by (U.S.)$0.27 or 0.97% to (U.S.)$27.99 and crossing above its 20-day moving average. Over the last five days, shares are unchanged, but are currently 1.82% below its 52-week high. This security has outperformed the S&P 500 by 5.39% during the last year.

Key company metrics

  • Open(U.S.) $27.78
  • Previous close(U.S.) $27.72
  • High(U.S.) $28.16
  • Low(U.S.) $27.61
  • Bid / Ask(U.S.) $27.99 / (U.S.) $28.00
  • YTD % change+29.40%
  • Volume3,823,347
  • Average volume (10-day)6,976,358
  • Average volume (1-month)6,947,093
  • Average volume (3-month)7,262,650
  • 52-week range(U.S.) $19.67 to (U.S.) $28.51
  • Beta1.11
  • Trailing P/E89.35×
  • P/E 1 year forward22.23×
  • Forward PEG1.98×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.31
Updated June 27 11:51 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.05%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue2,1602,1912,1052,126
Total other revenue--------
Total revenue2,1602,1912,1052,126
Gross profit1,5221,5861,5191,494
Total cost of revenue638605586632
Total operating expense1,7962,0511,7572,460
Selling / general / administrative791828768774
Research & development235256232222
Depreciation / amortization143137136135
Interest expense (income), net operating--------
Unusual expense (income)-2820515677
Other operating expenses, total17202020
Operating income364140348-334
Interest income (expense), net non-operating-57-58-58-59
Gain (loss) on sale of assets--------
Other--------
Income before tax30589257-397
Income after tax290124228-207
Income tax, total15-3529-190
Net income290124228-207
Total adjustments to net income--------
Net income before extra. items290124228-207
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items290124228-207
Inc. avail. to common incl. extra. items290124228-207
Diluted net income290124228-207
Dilution adjustment--------
Diluted weighted average shares1,3901,3841,3611,357
Diluted EPS excluding extraordinary itemsvalue per share0.210.090.17-0.15
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.190.190.180.17